Product Description

🔹 Product Overview
Ebunat 0.5 mg Injection is a prescription anti-cancer medicine used in the treatment of advanced and metastatic cancers.
Contains Eribulin Mesylate 0.5 mg, a microtubule inhibitor that helps stop the growth and spread of cancer cells.
Commonly prescribed for patients with metastatic breast cancer and liposarcoma after prior chemotherapy treatments.

🔹 Key Uses
Treatment of metastatic breast cancer
Management of advanced liposarcoma
Used in patients previously treated with chemotherapy
Helps slow progression of cancer cells

🔹 Composition
Active ingredient: Eribulin Mesylate 0.5 mg
Belongs to anti-neoplastic / microtubule inhibitor class
Used in oncology and chemotherapy treatment

🔹 How It Works
Interferes with microtubule structures in cancer cells
Prevents cancer cells from dividing and multiplying
Blocks tumor growth and helps destroy abnormal cells

🔹 Key Benefits
Effective chemotherapy injection for advanced cancers
Helps control spread of metastatic tumors
Used in specialized cancer treatment protocols
Supports management of difficult-to-treat cancers

🔹 Dosage and Administration
Administered only under medical supervision
Given intravenously by qualified healthcare professionals
Dosage depends on body surface area and medical condition
Regular blood tests may be required during treatment

🔹 Possible Side Effects
Hair loss
Weakness and fatigue
Nausea and constipation
Low white blood cell count
Tingling or numbness in hands and feet

🔹 Precautions
Use under strict oncologist supervision
Avoid use during pregnancy and breastfeeding
Inform doctor about liver, kidney, or heart conditions
Monitor blood counts regularly during therapy
Avoid self-administration